Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer

Table 3

Characteristics of the study group.

Patient number	Age	Gender	Etiology	Mackie classification	Ulcer size	Additional treatment	Additional surgical procedures	Corneal sensation
1	79	F	Herpes zoster	3	Big	Y	N	Lack
2	66	M	Herpes simplex	2	Big	Y	N	Weakened
3	60	F	Cranial nerve palsy	3	Big	Y	N	Lack
4	82	M	Cranial nerve palsy	2	Medium	N	N	Lack
5	89	M	Herpes simplex	3	Medium	Y	N	Lack
6	59	M	Cranial nerve palsy	3	Big	N	N	Lack
7	58	M	Herpes zoster	2	Big	Y	N	Lack
8	46	M	Cranial nerve palsy	2	Medium	N	N	Weakened
9	82	F	Herpes simplex	3	Big	Y	N	Lack
10	74	F	Cranial nerve palsy	2	Big	N	N	Weakened
11	43	F	Herpes simplex	3	Big	Y	Y	Lack
12	74	M	Cranial nerve palsy	3	Big	Y	N	Lack
13	83	M	Herpes simplex	3	Medium	Y	N	Lack
14	70	M	Herpes simplex	2	Small	Y	N	Weakened
15	80	M	Herpes simplex	2	Small	Y	N	Weakened
16	41	F	Cranial nerve palsy	2	Small	N	N	Lack
17	60	F	Herpes simplex	2	Small	Y	N	Lack
18	60	F	Cranial nerve palsy	3	Small	N	N	Lack
19	69	F	Cranial nerve palsy	2	Small	N	N	Lack
20	52	F	Herpes simplex	3	Medium	Y	N	Lack
21	74	F	Cranial nerve palsy	3	Medium	N	N	Lack
22	59	F	Cranial nerve palsy	3	Big	Y	N	Lack
23	81	F	Cranial nerve palsy	3	Big	Y	N	Lack
24	82	F	Herpes simplex	2	Medium	Y	N	Weakened
25	23	M	Cranial nerve palsy	2	Medium	N	N	Lack

F: female; M: male. Mackie classification stage 2: persistent epithelial defects with thickened and rolled edges, oedematous stroma, stage 3: corneal ulcer, stromal melting, impending perforation. Ulcer size (width and height): small: smaller or equal to 2 mm; medium: between 2 and 4 mm; big: greater than 4 mm. Y: yes; N: no.